샘플 요청 목록

 카트 문의
시장보고서
상품코드
1551480

세계의 알코올성 간염 치료 시장

Alcoholic Hepatitis Treatment
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 265 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

알코올성 간염 치료 시장은 2030년까지 30억 달러에 도달할 전망입니다.

2023년에 22억 달러로 추정된 알코올성 간염 치료 시장은 예측 기간 동안 복합 연간 성장률(CAGR) 4.4%로 성장할 전망이며 2030년에는 30억 달러에 이를 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 부신피질 스테로이드는 복합 연간 성장률(CAGR) 4.4%로 성장을 지속하고, 분석 기간 종료 시 17억 달러에 달할 것으로 예측됩니다. 치질 치료제 부문의 성장률은 분석 기간 동안 복합 연간 성장률(CAGR) 3.9%로 추정됩니다.

미국 시장은 추정 6억 310만 달러, 중국은 복합 연간 성장률(CAGR) 7.3%로 성장 할 것으로 예측됩니다.

미국의 알코올성 간염 치료 시장은 2023년 6억 310만 달러로 추정됩니다. 세계의 2위 경제대국인 중국은 예측 기간 동안 복합 연간 성장률(CAGR) 7.3%로 성장을 지속하여 2030년에는 6억870만 달러 규모에 이를 것으로 예측되고 있습니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 복합 연간 성장률(CAGR)은 각각 1.7%와 4.7%로 예측되고 있습니다. 유럽에서는 독일이 복합 연간 성장률(CAGR) 2.6%로 성장할 것으로 예측됩니다.

세계의 알코올성 간염 치료 시장 - 주요 동향과 촉진요인 요약

알코올성 간염 치료의 주요 접근법이란?

알코올성 간염은 알코올의 과다 복용으로 인한 간의 심한 염증 상태이며, 치료에는 다면적 접근이 필요합니다. 첫 번째 전략은 알코올 섭취를 즉시 중단하는 것이며, 이는 추가적인 간 장애를 막기 위해 매우 중요합니다. 종종 의학적 개입은 지원 요법으로 시작하여 환자들 사이에서 널리 보이는 증상과 영양 불량과 같은 합병증을 다룹니다. 영양 지원, 특히 단백질과 비타민의 보충은 간 기능과 전체 환자의 건강을 개선하는 데 필수적입니다. 프레드니솔론과 같은 부신 피질 스테로이드는 심한 경우 간의 염증을 억제하는 데 일반적으로 사용됩니다. 그러나 부신 피질 스테로이드의 효능은 다양하며 면역 결핍 환자에서 감염의 위험으로 인해 그 사용이 자주 논의됩니다. 또한 간이식이 필요한 간부전 등 합병증의 관리도 중요한 치료입니다. 알코올성 간염 치료의 복잡성으로 인해 환자의 전신 상태, 질병의 중증도, 병존 질환을 고려한 개별 케어 플랜의 필요성이 부각됩니다.

새로운 조사는 알코올성 간염 치료의 진보에 어떤 역할을 하는가?

새로운 연구는 질병의 메커니즘과 잠재적인 치료 표적에 대한 새로운 인사이트을 제공하여 알코올성 간염 치료의 상황을 변화시킵니다. 알코올성 간염의 원인이 되는 분자적,유전적 요인의 해명이 진행되어, 질병의 진행을 수정하는 것을 목적으로 한 새로운 치료법의 개발이 진행되고 있습니다. 예를 들어, 장-간축 상호작용의 연구는 장내 세균총이 알코올성 간염의 발병 및 중증화에 중요한 역할을 하는 것으로 밝혀졌습니다. 이 때문에 잠재적인 치료 개입으로서 프로바이오틱스나 대변 미생물총 이식의 연구가 진행되고 있습니다. 또한, 간 염증에 관여하는 특정 면역 경로를 표적으로 하는 면역 요법이 알코올성 간염의 유망한 치료법으로 주목받고 있습니다. 현재 IL-1 억제제와 TNF-α 차단제 등 간의 염증을 억제하고 환자의 예후를 개선할 가능성을 보여주는 다양한 생물학적 제제의 효능을 평가하는 임상시험이 진행 중입니다. 이 분야에서 R및D의 급속한 페이스는 가까운 미래에 보다 효과적이고 개인화된 치료법의 선택을 가져올 것으로 기대됩니다.

헬스케어 시스템은 알코올성 간염의 과제를 어떻게 다루고 있는가?

알코올성 간염은 복잡한 질환이며 알코올 남용이 많은 것이 주된 원인입니다. 주요 과제 중 하나는 알코올성 간염의 조기 진단입니다. 알코올성 간염은 종종 비특이적 증상을 나타내며 다른 간 질환과 잘못 될 수 있기 때문입니다. 이 문제를 해결하기 위해 의료 서비스 제공업체는 조기 발견과 예후를 개선하기 위해 비침습적 이미징 기술과 바이오마커를 포함한 고급 진단 도구의 활용을 점차 추진하고 있습니다. 또한, 환자에게 종합적인 케어를 제공하기 위해 간 전문의, 영양사, 심리학자, 소셜 워커를 포함한 집학적 케어 팀을 통합하는 것이 중요해지고 있습니다. 이 접근법은 치료에서 심리 사회적 지원에 이르기까지 질병의 모든 측면을 확실하게 해결할 수 있습니다. 또한 건강 관리 시스템은 알코올성 간염의 발병률을 낮추기 위해 공중 보건 캠페인 및 금주 프로그램과 같은 예방 조치에 힘을 쏟고 있습니다. 이러한 노력은 과도한 알코올 섭취 위험에 대한 인식을 높이고 알코올 중독으로 고민하는 사람들에게 자원을 제공하는 것을 목표로합니다.

알코올성 간염 치료 시장 성장의 원동력은?

알코올성 간염 치료 시장의 성장은 기술의 진보, 소비자 행동의 변화, 건강 관리 관행의 진화를 반영하는 여러 요인에 의해 견인되고 있습니다. 주요 요인 중 하나는 세계의 알코올 사용 장애(AUD)의 유병률 증가이며, 이로 인해 알코올성 간염의 발생률이 높아져 효과적인 치료에 대한 수요가 높아지고 있습니다. 진단과 치료의 기술적 진보도 시장 성장에 기여합니다. 비침습적 간 영상 진단, 차세대 시퀀싱, 정밀의료 등의 기술 혁신은 보다 정확한 진단과 개인화된 치료 접근을 가능하게 하여 환자의 결과를 개선하고 시장을 확대하고 있습니다. 또 다른 중요한 요인은 알코올성 간염의 중증 사례에 대한 실행 가능한 치료 옵션으로 간 이식에 대한 인식과 수용이 증가하고 있다는 것입니다. 또한 환자 모니터링 및 치료 프로토콜 준수를 강화하기 위해 원격 의료 및 모바일 건강 앱과 같은 디지털 건강 솔루션의 통합이 중요해졌습니다. 조기 개입과 종합적 케어에 대한 관심이 높아짐에 따라 이러한 기술적 발전이 알코올성 간염 치료 시장의 확대를 촉진하는 주요 요인이 되고 있습니다.

조사 대상 기업 예(주목의 25개사)

  • Aldeyra Therapeutics, Inc
  • Anuh Pharma Ltd
  • Arrowhead Pharmaceuticals Inc.
  • Cation Chemical
  • Cipla
  • Durect Corporation
  • Evive Biotech
  • HighTide Therapeutics, Inc.
  • Hovione
  • Nordic Bioscience A/S
  • Steroid SpA
  • Surrozen, Inc.
  • Symbiotec Pharmalab
  • Taj Pharma Group
  • ZyVersa Therapeutics, Inc.;

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

BJH 24.09.19

Global Alcoholic Hepatitis Treatment Market to Reach US$3.0 Billion by 2030

The global market for Alcoholic Hepatitis Treatment estimated at US$2.2 Billion in the year 2023, is expected to reach US$3.0 Billion by 2030, growing at a CAGR of 4.4% over the analysis period 2023-2030. Corticosteroids, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$1.7 Billion by the end of the analysis period. Growth in the Hemorrheologic Agents segment is estimated at 3.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$603.1 Million While China is Forecast to Grow at 7.3% CAGR

The Alcoholic Hepatitis Treatment market in the U.S. is estimated at US$603.1 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$608.7 Million by the year 2030 trailing a CAGR of 7.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.7% and 4.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.6% CAGR.

Global Alcoholic Hepatitis Treatment Market - Key Trends and Drivers Summarized

What Are the Key Approaches in Alcoholic Hepatitis Treatment?

Alcoholic hepatitis, a severe inflammatory condition of the liver caused by excessive alcohol consumption, demands a multifaceted approach to treatment. The primary strategy focuses on immediate cessation of alcohol intake, which is crucial for halting further liver damage. Medical interventions often begin with supportive care, addressing the symptoms and complications such as malnutrition, which is prevalent among patients. Nutritional support, particularly protein and vitamin supplementation, is vital for improving liver function and overall patient health. Corticosteroids, such as prednisolone, are commonly used to reduce liver inflammation in severe cases. However, the effectiveness of corticosteroids can vary, and their use is often debated due to the risk of infections in immunocompromised patients. Another critical treatment aspect is managing complications such as liver failure, which may require liver transplantation. The complexity of alcoholic hepatitis treatment highlights the need for individualized care plans, which consider the patient's overall health, the severity of the disease, and any coexisting conditions.

What Role Does Emerging Research Play in Advancing Alcoholic Hepatitis Treatment?

Emerging research is transforming the landscape of alcoholic hepatitis treatment, offering new insights into disease mechanisms and potential therapeutic targets. Advances in understanding the molecular and genetic factors that contribute to alcoholic hepatitis have led to the development of novel therapies aimed at modifying disease progression. For instance, research into gut-liver axis interactions has revealed that gut microbiota plays a significant role in the development and severity of alcoholic hepatitis. This has prompted studies on probiotics and fecal microbiota transplantation as potential therapeutic interventions. Additionally, immunotherapy is gaining attention as a promising avenue for treating alcoholic hepatitis by targeting specific immune pathways involved in liver inflammation. Clinical trials are currently underway to evaluate the efficacy of various biologics, such as IL-1 inhibitors and TNF-alpha blockers, which have shown potential in reducing liver inflammation and improving patient outcomes. The rapid pace of research and development in this field holds promise for more effective and personalized treatment options in the near future.

How Are Healthcare Systems Addressing the Challenges of Alcoholic Hepatitis?

Healthcare systems worldwide face significant challenges in managing alcoholic hepatitis, largely due to the disease's complex nature and the high prevalence of alcohol abuse. One of the primary challenges is the early diagnosis of alcoholic hepatitis, as the disease often presents with non-specific symptoms that can be mistaken for other liver conditions. To address this, healthcare providers are increasingly utilizing advanced diagnostic tools, including non-invasive imaging techniques and biomarkers, to improve early detection and prognosis. Moreover, there is a growing emphasis on integrating multidisciplinary care teams, including hepatologists, nutritionists, psychologists, and social workers, to provide comprehensive care for patients. This approach ensures that all aspects of the disease, from medical treatment to psychosocial support, are addressed. Additionally, healthcare systems are focusing on preventive measures, such as public health campaigns and alcohol cessation programs, to reduce the incidence of alcoholic hepatitis. These initiatives aim to raise awareness about the risks of excessive alcohol consumption and provide resources for individuals struggling with alcohol addiction.

What Is Driving Growth in the Alcoholic Hepatitis Treatment Market?

The growth in the alcoholic hepatitis treatment market is driven by several factors that reflect advancements in technology, changing consumer behavior, and evolving healthcare practices. One of the primary drivers is the increasing prevalence of alcohol use disorder (AUD) worldwide, which has led to a higher incidence of alcoholic hepatitis and, consequently, a greater demand for effective treatments. Technological advancements in diagnostics and therapeutics are also contributing to market growth. Innovations such as non-invasive liver imaging, next-generation sequencing, and precision medicine are enabling more accurate diagnosis and personalized treatment approaches, thereby improving patient outcomes and expanding the market. Another significant factor is the rising awareness and acceptance of liver transplantation as a viable treatment option for severe cases of alcoholic hepatitis, supported by improvements in surgical techniques and post-transplant care. Furthermore, there is a growing emphasis on integrating digital health solutions, such as telemedicine and mobile health apps, to enhance patient monitoring and adherence to treatment protocols. These technological developments, coupled with an increasing focus on early intervention and comprehensive care, are key drivers propelling the expansion of the alcoholic hepatitis treatment market.

Select Competitors (Total 25 Featured) -

  • Aldeyra Therapeutics, Inc
  • Anuh Pharma Ltd
  • Arrowhead Pharmaceuticals Inc.
  • Cation Chemical
  • Cipla
  • Durect Corporation
  • Evive Biotech
  • HighTide Therapeutics, Inc.
  • Hovione
  • Nordic Bioscience A/S
  • Steroid SpA
  • Surrozen, Inc.
  • Symbiotec Pharmalab
  • Taj Pharma Group
  • ZyVersa Therapeutics, Inc.;

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Alcoholic Hepatitis Treatment - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Alcohol Use Disorders Expands Addressable Market Opportunity for Alcoholic Hepatitis Treatment
    • Advancements in Immunotherapy Propel Growth in Targeted Alcoholic Hepatitis Treatment Options
    • Focus on Early Diagnosis and Intervention Drives Adoption of Innovative Therapeutic Approaches
    • Development of Biologics and Regenerative Medicine Strengthens Business Case for Next-Generation Alcoholic Hepatitis Treatments
    • Integration of Personalized Medicine and Genomic Insights Throws the Spotlight on Tailored Treatment Strategies
    • Growing Awareness and Screening Initiatives Spur Growth in Preventive and Early-Stage Treatment Solutions
    • Rising Healthcare Expenditure and Access to Advanced Care Generate Demand for Premium Alcoholic Hepatitis Therapies
    • Challenges in Managing Severe Cases Present Opportunities for Innovation in Combination Therapy Approaches
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Alcoholic Hepatitis Treatment Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Alcoholic Hepatitis Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Alcoholic Hepatitis Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Corticosteroids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Corticosteroids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Corticosteroids by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Hemorrheologic Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Hemorrheologic Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Hemorrheologic Agents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Anabolic Steroids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Anabolic Steroids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Anabolic Steroids by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Drug Classes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Drug Classes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Other Drug Classes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Online Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Alcoholic Hepatitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Alcoholic Hepatitis Treatment by Drug Class - Percentage Breakdown of Value Sales for Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Alcoholic Hepatitis Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Alcoholic Hepatitis Treatment by Drug Class - Percentage Breakdown of Value Sales for Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Alcoholic Hepatitis Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2014, 2024 & 2030
  • JAPAN
    • Alcoholic Hepatitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Alcoholic Hepatitis Treatment by Drug Class - Percentage Breakdown of Value Sales for Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Alcoholic Hepatitis Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2014, 2024 & 2030
  • CHINA
    • Alcoholic Hepatitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Alcoholic Hepatitis Treatment by Drug Class - Percentage Breakdown of Value Sales for Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: China 16-Year Perspective for Alcoholic Hepatitis Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2014, 2024 & 2030
  • EUROPE
    • Alcoholic Hepatitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Alcoholic Hepatitis Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Alcoholic Hepatitis Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Alcoholic Hepatitis Treatment by Drug Class - Percentage Breakdown of Value Sales for Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Alcoholic Hepatitis Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2014, 2024 & 2030
  • FRANCE
    • Alcoholic Hepatitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Alcoholic Hepatitis Treatment by Drug Class - Percentage Breakdown of Value Sales for Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: France 16-Year Perspective for Alcoholic Hepatitis Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2014, 2024 & 2030
  • GERMANY
    • Alcoholic Hepatitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Alcoholic Hepatitis Treatment by Drug Class - Percentage Breakdown of Value Sales for Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Alcoholic Hepatitis Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Alcoholic Hepatitis Treatment by Drug Class - Percentage Breakdown of Value Sales for Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Alcoholic Hepatitis Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Alcoholic Hepatitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Alcoholic Hepatitis Treatment by Drug Class - Percentage Breakdown of Value Sales for Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Alcoholic Hepatitis Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Alcoholic Hepatitis Treatment by Drug Class - Percentage Breakdown of Value Sales for Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Spain 16-Year Perspective for Alcoholic Hepatitis Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Alcoholic Hepatitis Treatment by Drug Class - Percentage Breakdown of Value Sales for Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Russia 16-Year Perspective for Alcoholic Hepatitis Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Alcoholic Hepatitis Treatment by Drug Class - Percentage Breakdown of Value Sales for Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Alcoholic Hepatitis Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Alcoholic Hepatitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Alcoholic Hepatitis Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Alcoholic Hepatitis Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Alcoholic Hepatitis Treatment by Drug Class - Percentage Breakdown of Value Sales for Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Alcoholic Hepatitis Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Alcoholic Hepatitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Alcoholic Hepatitis Treatment by Drug Class - Percentage Breakdown of Value Sales for Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Australia 16-Year Perspective for Alcoholic Hepatitis Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2014, 2024 & 2030
  • INDIA
    • Alcoholic Hepatitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: India 16-Year Perspective for Alcoholic Hepatitis Treatment by Drug Class - Percentage Breakdown of Value Sales for Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: India 16-Year Perspective for Alcoholic Hepatitis Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Alcoholic Hepatitis Treatment by Drug Class - Percentage Breakdown of Value Sales for Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: South Korea 16-Year Perspective for Alcoholic Hepatitis Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Alcoholic Hepatitis Treatment by Drug Class - Percentage Breakdown of Value Sales for Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Alcoholic Hepatitis Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Alcoholic Hepatitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Alcoholic Hepatitis Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Alcoholic Hepatitis Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Alcoholic Hepatitis Treatment by Drug Class - Percentage Breakdown of Value Sales for Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Alcoholic Hepatitis Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Alcoholic Hepatitis Treatment by Drug Class - Percentage Breakdown of Value Sales for Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Argentina 16-Year Perspective for Alcoholic Hepatitis Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Alcoholic Hepatitis Treatment by Drug Class - Percentage Breakdown of Value Sales for Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Brazil 16-Year Perspective for Alcoholic Hepatitis Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Alcoholic Hepatitis Treatment by Drug Class - Percentage Breakdown of Value Sales for Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Mexico 16-Year Perspective for Alcoholic Hepatitis Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Alcoholic Hepatitis Treatment by Drug Class - Percentage Breakdown of Value Sales for Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Rest of Latin America 16-Year Perspective for Alcoholic Hepatitis Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Alcoholic Hepatitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Alcoholic Hepatitis Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Alcoholic Hepatitis Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Alcoholic Hepatitis Treatment by Drug Class - Percentage Breakdown of Value Sales for Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Alcoholic Hepatitis Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Alcoholic Hepatitis Treatment by Drug Class - Percentage Breakdown of Value Sales for Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Iran 16-Year Perspective for Alcoholic Hepatitis Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Alcoholic Hepatitis Treatment by Drug Class - Percentage Breakdown of Value Sales for Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Israel 16-Year Perspective for Alcoholic Hepatitis Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Alcoholic Hepatitis Treatment by Drug Class - Percentage Breakdown of Value Sales for Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Saudi Arabia 16-Year Perspective for Alcoholic Hepatitis Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Alcoholic Hepatitis Treatment by Drug Class - Percentage Breakdown of Value Sales for Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: UAE 16-Year Perspective for Alcoholic Hepatitis Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Alcoholic Hepatitis Treatment by Drug Class - Percentage Breakdown of Value Sales for Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Rest of Middle East 16-Year Perspective for Alcoholic Hepatitis Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2014, 2024 & 2030
  • AFRICA
    • Alcoholic Hepatitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Alcoholic Hepatitis Treatment by Drug Class - Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Alcoholic Hepatitis Treatment by Drug Class - Percentage Breakdown of Value Sales for Corticosteroids, Hemorrheologic Agents, Anabolic Steroids and Other Drug Classes for the Years 2014, 2024 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Alcoholic Hepatitis Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 211: Africa 16-Year Perspective for Alcoholic Hepatitis Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제